Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-04

Clinical Trial Update: Effect of JAK Inhibitor on Erosion Healing in RA [Phase 4]

View source ↗

Summary

A Phase 4 trial sponsored by the Chinese University of Hong Kong is examining the effect of a JAK inhibitor on erosion healing in rheumatoid arthritis and is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • JAK inhibitor

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Rheumatoid Arthritis | Phase 4 | Status: RECRUITING